-
Experiments in development: Time to rethink RCTs?
Randomized controlled trials, an impact evaluation method, have been a contentious development issue of late, with as many advocates as critics. A Devex survey of senior development executives across six continents and varied organizations revealed that nearly half aren’t familiar with the debate or have no opinion at all. This indicates that while RCTs remain a hot topic among academics and practitioners, the issue is not yet relevant to many senior managers. Another sizable group — 37 percent of executives surveyed — responded that RCTs are “somewhat overhyped.”
- Categories
- Education
- Tags
- research
-
GlaxoSmithKline, NewLink working to bring Ebola vaccines online: WHO
Both GlaxoSmithKline and NewLink Genetics are working to boost their capacity to make Ebola vaccines, with a goal of a "very significant increase in scale during the first half of 2015," the World Health Organization said on Wednesday.
- Categories
- Health Care
-
Handling the next pandemic
Can the global health system stop Ebola? The answer has more to do with Samuel Kaziraho than you might expect.
- Categories
- Health Care
-
Developing countries should enroll medical and nursing students from rural areas
Nearly one third of medical and nursing students in developing countries may have no intention of working in their own countries after graduation, while less than one fifth of them intend to work in rural areas where they are needed most, according to a new study.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
Ebola Researchers Have A Radical Idea: Rush A Vaccine Into The Field
Traditional means of containing Ebola aren't working fast enough to get ahead of the epidemic. So the question is: Will giving an experimental vaccine to willing volunteers help contain the disease or put people at greater risk?
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
Shares of Companies Testing Ebola Vaccines Rise
Shares of some companies that are studying potential vaccines for Ebola climbed after federal officials announced that the first case of the disease has been diagnosed in the U.S.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Mobile technology offers option to combat fake drugs in West Africa
Cholera, malaria and the rapidly expanding threat of Ebola have hit African countries with a related health-care problem: the scourge of fake drugs.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa
-
MFI credit bureau on course in Ghana
Work on a credit referencing system for the microfinance sector is scheduled to be completed by middle of next year, the Ghana Association of Microfinance Companies (GAMC) has said.
- Categories
- Uncategorized
- Region
- Sub-Saharan Africa
- Tags
- lending, microfinance
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.